Related Articles
Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model
Gain‑of‑function of IDO in DCs inhibits T cell immunity by metabolically regulating surface molecules and cytokines
IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion
Whole-cell vaccine coated with recombinant calreticulin enhances activation of dendritic cells and induces tumour-specific immune responses
Dendritic cells transfected with lentiviral vector-encoding hTERT peptide augment antitumor T cell response in vitro